Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

ClinicalTrials.gov ID: NCT00069017

Public ClinicalTrials.gov record NCT00069017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind Study to Evaluate the Effects of MEDI-522, a Humanized MAb to Integrin Alpha V Beta 3, On Disease Activity and Progression of Joint Damage in Pts With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

Study identification

NCT ID
NCT00069017
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • MEDI-522 Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2003
Primary completion
Not listed
Completion
Mar 31, 2006
Last update posted
Nov 26, 2007

2003 – 2006

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
The University of Alabama at Birmingham Birmingham Alabama 35249-7201
Sun Valley Arthritis Center Glendale Arizona 85308
Arizona Research & Education Phoenix Arizona 85012
University of Arizona Tucson Arizona 85724
Fayetteville Diagnostic Clinic, Ltd. Fayetteville Arkansas 72703
Thornton Hospital La Jolla California 92037-0943
Boling Clinical Trials Rancho Cucamonga California 91730
Pacific Arthritis Center Medical Group Santa Maria California 93454
Arthritis and Rheumatic Disease Specialty Aventura Florida 33180
Centre for Rheumatology, Immunology & Arthritis Fort Lauderdale Florida 33334
Ocala Rheumatology Research Center Ocala Florida 34474
Sarasota Arthritis Research Center Sarasota Florida 34239
Sanford S. Hartman Decatur Georgia 30033
Center for Rheumatology and Bone Research Wheaton Maryland 20902
RIMA St Louis Missouri 63131
Arthritis Consultants, Inc. St Louis Missouri 63141
Rheumatology Associates of New Jersey Teaneck New Jersey 07666
The Center for Rheumatology Albany New York 12206
Health Research Institute Oklahoma City Oklahoma 73109
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Oklahoma Center for Arthritis Therapy and Research Inc. Tulsa Oklahoma 74114
Amarillo Center for Clinical Research Amarillo Texas 79124
Radiant Research Dallas Texas 75235
Arthritis & Osteoporosis Associates, LLP Lubbock Texas 79410
University of Utah Medical Hospital Salt Lake City Utah 84132
The Physician's Clinic of Spokane Spokane Washington 99204
Rheumatology Northwest/Clinical Trials Northwest Yakima Washington 98902
Gundersen Clinic Ltd. La Crosse Wisconsin 54601
University of Wisconsin Hospital & Clinics Madison Wisconsin 53792-3244

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00069017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2007 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00069017 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →